Postnatal Corticosteroids Policy for Very Preterm Infants and Bronchopulmonary Dysplasia

Introduction: Postnatal corticosteroids (PNC) are effective for reducing bronchopulmonary dysplasia (BPD) in very preterm neonates but are associated with adverse effects including an increased risk of cerebral palsy. PNC use in Europe is heterogeneous across regions. This study aimed to assess whet...

Full description

Bibliographic Details
Main Author: Nuytten, A (author)
Other Authors: Behal, H (author), Duhamel, A (author), Jarreau, PH (author), Torchin, H (author), Milligan, D (author), Maier, RF (author), Zemlin, M (author), Zeitlin, J (author), Truffert, P (author), EPICE Research Group (author)
Format: article
Language:eng
Published: 2020
Subjects:
Bronchopulmonary dysplasia
EPICE cohort
Postnatal corticosteroids
Very preterm infants
Online Access:https://hdl.handle.net/10216/143316
Country:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/143316

Internet

https://hdl.handle.net/10216/143316

Similar Items